Featured! - 74%

MDMA and Psychotherapy – Michael Mithoefer

Name: MDMA And Psychotherapy - Michael Mithoefer - $36
Brand: WSOVision
SKU: 5a93c4e83bdc
Availability: InStock

Add your review

Original price was: $119.99.Current price is: $31.00.

(-74%)

MDMA and Psychotherapy – Michael Mithoefer has the same quality as the author’s salapage.

Michael Mithoefer

SKU: 5a93c4e83bdc Category: Health and Medical Tag: MDMA and Psychotherapy , Michael Mithoefer

Description
Additional information
Reviews (0)

Salepage link: At HERE. Archive:

Faculty:: Michael Mithoefer
Duration:: 2 Hours 59 Minutes
Format:: Audio and Video
Copyright:: Mar 25, 2018

Description

For millennia, cultures around the world have embraced mind-altering substances to catalyze healing. Western psychotherapy has generally resisted the healing potential of such substances, but the FDA has lately approved clinical trials using MDMA—also known as Ecstasy, or Molly—to treat PTSD. Psychotherapists have a major role to play in these treatments, by helping clients process the healing shifts in consciousness that can occur on the drug.

Outline

History of MDMA

MDMA as Psychedelic
MDMA Pharmacology
MDMA Therapy Use in the 1970’s and 1980’s

Clinical Trials & Results

Study Design
Neuropsychology Measures
Study with Veterans, Firefighters, & Police Officers
Drug Treatment Development Protocol with Couples
MDMA Therapy with Therapists
MDMA Side Effects

Therapeutic Approach / MDMA in Psychotherapy

Video Case Study
Manual for MDMA Assisted Psychotherapy
Why Does MDMA Work?
Imaging
MDMA Assisted Psychotherapy Agreements

The Future of MDMA Assisted Psychotherapy

Further Research
Expanded Access Clinics
Training Program

Faculty

Michael Mithoefer, MD Related seminars and products: 1

Michael Mithoefer, MD, is a psychiatrist who specializes in experiential methods of psychotherapy to treat PTSD. Now focused on MDMA clinical research, he’s completed studies with treatment-resistant PTSD, and with veterans, firefighters, and police officers with PTSD. He’s training therapists for a nonprofit, phase-3 clinical trial of MDMA-assisted psychotherapy for PTSD.